SINGAPORE,First and only chemotherapy-free combination in the first-line setting to demonstrate an overall survival benefit versus osimertinib among Asian patients.

In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen ...

SLS009 in combination with AZA/VEN achieved a 46% overall response rate across all cohorts, a 58% overall response rate in patients with one prior line of therapy, and encouraging survival outcomes in ...

Bizarre changes in animal behaviour and appearance have unfolded at the highly reactive Chernobyl site in the 40 years since ...

"Stranger Things" is coming to a close this holiday. As we leave Hawkins, we have five Netflix series that could become the ...

Among fit patients with acute myeloid leukemia, the combination of azacitidine plus Venclexta (venetoclax) was associated ...

Azacitidine plus venetoclax (Venclexta) demonstrated significantly improved event-free survival (EFS) vs intensive induction chemotherapy in patients with acute myeloid leukemia (AML), according to ...

OS for Black patients was 57.8 months in those with a favorable ELN cytogenic RS, 14.2 months for those with intermediate RS ...

Scientists are studying the long-term effects of radiation on feral dogs living in the Chernobyl Exclusion Zone.

Matters arising out of the Agrarian Reforms Act especially resumption proceedings fall exclusively within the domain of ...

Compared with white patients, Black patients with acute myeloid leukemia (AML) were on average more than five years younger ...

They’re not turning blue. But are the stray dogs roaming Chernobyl’s radioactive wasteland undergoing rapid evolutionary ...